| Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 1852 | 2020 |
| Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study I Cleynen, G Boucher, L Jostins, LP Schumm, S Zeissig, T Ahmad, ... The Lancet 387 (10014), 156-167, 2016 | 825 | 2016 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 718 | 2021 |
| Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota J Wang, LB Thingholm, J Skiecevičienė, P Rausch, M Kummen, JR Hov, ... Nature genetics 48 (11), 1396-1406, 2016 | 609 | 2016 |
| Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failure M Trøseid, T Ueland, JR Hov, A Svardal, I Gregersen, CP Dahl, S Aakhus, ... Journal of internal medicine 277 (6), 717-726, 2015 | 454 | 2015 |
| Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ... Nature genetics 45 (6), 670-675, 2013 | 431 | 2013 |
| Genome-wide association analysis in primary sclerosing cholangitis TH Karlsen, A Franke, E Melum, A Kaser, JR Hov, T Balschun, BA Lie, ... Gastroenterology 138 (3), 1102-1111, 2010 | 404 | 2010 |
| The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls M Kummen, K Holm, JA Anmarkrud, S Nygård, M Vesterhus, ML Høivik, ... Gut 66 (4), 611-619, 2017 | 384 | 2017 |
| Gut microbiota diversity predicts immune status in HIV-1 infection P Nowak, M Troseid, E Avershina, B Barqasho, U Neogi, K Holm, JR Hov, ... Aids 29 (18), 2409-2418, 2015 | 372 | 2015 |
| Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci E Melum, A Franke, C Schramm, TJ Weismüller, DN Gotthardt, FA Offner, ... Nature genetics 43 (1), 17-19, 2011 | 286 | 2011 |
| The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions M Trøseid, GØ Andersen, K Broch, JR Hov EBioMedicine 52, 2020 | 254 | 2020 |
| Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci T Folseraas, E Melum, P Rausch, BD Juran, E Ellinghaus, A Shiryaev, ... Journal of hepatology 57 (2), 366-375, 2012 | 242 | 2012 |
| Autoantibodies in primary sclerosing cholangitis JR Hov, KM Boberg, TH Karlsen World journal of gastroenterology: WJG 14 (24), 3781, 2008 | 225 | 2008 |
| Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease AK Lunder, JR Hov, A Borthne, J Gleditsch, G Johannesen, K Tveit, ... Gastroenterology 151 (4), 660-669. e4, 2016 | 223 | 2016 |
| Genome‐wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 D Ellinghaus, T Folseraas, K Holm, E Ellinghaus, E Melum, T Balschun, ... Hepatology 58 (3), 1074-1083, 2013 | 200 | 2013 |
| Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts M Kummen, CCK Mayerhofer, B Vestad, K Broch, A Awoyemi, ... Journal of the American College of Cardiology 71 (10), 1184-1186, 2018 | 171 | 2018 |
| Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation SF Jørgensen, M Trøseid, M Kummen, JA Anmarkrud, AE Michelsen, ... Mucosal immunology 9 (6), 1455-1465, 2016 | 145 | 2016 |
| Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis M Vesterhus, JR Hov, A Holm, E Schrumpf, S Nygård, K Godang, ... Hepatology 62 (1), 188-197, 2015 | 140 | 2015 |
| The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis K Skagen, M Trøseid, T Ueland, S Holm, A Abbas, I Gregersen, ... Atherosclerosis 247, 64-69, 2016 | 138 | 2016 |
| Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis JR Hov, V Keitel, JK Laerdahl, L Spomer, E Ellinghaus, A ElSharawy, ... PloS one 5 (8), e12403, 2010 | 138 | 2010 |
